The company
Heartflow, Inc.
HTFL · Nasdaq
HTFL stood above a rising 150-day average in 9 of the last 27 weekly readings, including each of the last 9 weeks. It is 39.6% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 9 in a row
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $1.1M
- Insider sales, 12 months
- $278.1M
- Officials’ trades on record
- 0
- Institutions holding
- 185 (+24)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 9 of 27 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| John C.m. FarquharChief Executive Officer | sold | 38,900at $49.57 | 12 Oct 2026filed 14 Oct 2026 |
| Vikram VergheseChief Financial Officer | sold | 16,766at $50.75 | 18 Sep 2026filed 18 Sep 2026 |
| Campbell RogersChief Medical Officer | sold | 19,682at $50.15 | 18 Sep 2026filed 21 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 7,579at $50.11 | 17 Sep 2026filed 18 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 668at $50.01 | 15 Sep 2026filed 15 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 4,593at $50.24 | 14 Sep 2026filed 15 Sep 2026 |
| John C.m. FarquharChief Executive Officer | sold | 3,890at $50.00 | 11 Sep 2026filed 14 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 29,714at $50.06 | 11 Sep 2026filed 15 Sep 2026 |
| John C.m. FarquharChief Executive Officer | sold | 35,010at $46.42 | 10 Sep 2026filed 14 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 6,640at $50.03 | 8 Sep 2026filed 10 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 27,540at $49.69 | 3 Sep 2026filed 4 Sep 2026 |
| Vikram VergheseChief Financial Officer | sold | 5,876at $50.60 | 2 Sep 2026filed 4 Sep 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Bain Capital Life Sciences Investors, LLCreduced · filed 14 Aug 2026 | 8,448,158$247.9M | -2,000,000−19.1% |
| WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 2026 | 7,864,226$230.7M | -4,118,057−34.4% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 5,197,747$152.5M | +3,735,163+255.4% |
| FMR LLCreduced · filed 13 Aug 2026 | 4,820,944$141.4M | -576,858−10.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 3,584,428$105.2M | +1,538,490+75.2% |
| BAMCO INCreduced · filed 14 Aug 2026 | 3,225,133$94.6M | -602,398−15.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,753,206$80.8M | +859,711+45.4% |
| Jupiter Topco LLCnew · filed 14 Aug 2026 | 2,419,336$71.0M | +2,419,336 |
| Invesco Ltd.added · filed 14 Aug 2026 | 2,298,718$67.4M | +385,628+20.2% |
| ALLIANCEBERNSTEIN L.P.added · filed 14 Aug 2026 | 1,924,268$46.8M | +699,942+57.2% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.